Skip to content

AcrySof™ IQ Vivity™ DAT615 (REF DAT615.235)Recalls & reported problems

Alcon Laboratories, Inc. · STERILE UV ABSORBING ACRYLIC FOLDABLE ASPHERIC X-WAVE™ POSTERIOR CHAMBER INTRAOCULAR LENS · Class 3 · Implant

All models of AcrySof IQ Vivity (225)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652426343), received between Nov 8, 2022 and Nov 8, 2022 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Corneal Edema1
  • Inflammation1
  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 8, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED THAT FOLLOWING A CATARACT EXTRACTION WITH AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED DECREASED BEST CORRECTED VISUAL ACUITY (BCVA). ADDITIONAL INFORMATION WAS RECEIVED STATING THAT ON POST-OP DAY 1, THE PATIENT EXPERIENCED VISION LIMITED, EDEMA AND INFLAMMATION AND USED ANTIBIOTIC AND STEROID MEDICATION. ONE WEEK LATER, THE POST-OP PATIENT WAS DOING WELL AND FINISHED WITH ANTIBIOTIC STEROID MEDICATION.

    Patient problems: Corneal Edema; Inflammation; Visual Impairment

    MAUDE report 15752786 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page